Your story awaits

Cantos Ventures
Cantos Ventures
42
companies
148
Jobs
resistanceBio
resistanceBio
resistance.bio

Size

11-50 employees

founded in

September 2021

resistanceBio has built the first cancer treatment resistance system to predict how multiple cancer types will respond to approved or novel treatments. The ResCu platform aims only to advance therapies that have the potential to be superior to the standard of care and significantly extend patients’ lives. ResCu addresses the root cause of treatment failure, which is treatment resistance.

Something looks off?
Open jobs at resistanceBio